Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag for Thrombocytopenia in Chronic Liver Disease
NCT00914927Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2009
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag in Thrombocytopenia, sponsored by Eisai Co., Ltd.. Started May 2009; status: completed.
02
Drugs
avatrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00914927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914927.